Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 8/20 | 0.59 |
| ▸ | HTR1A | P08908 | 7/20 | 0.57 |
| ▸ | HTR2C | P28335 | 2/20 | 0.49 |
| ▸ | HTR2B | P41595 | 2/20 | 0.49 |
| ▸ | MPO | P05164 | 6/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.39 |
| ▸ | DRD1 | P21728 | 1/20 | 0.37 |
| ▸ | HTR1D | P28221 | 1/20 | 0.37 |
| ▸ | HTR1B | P28222 | 1/20 | 0.37 |
| ▸ | HTR1E | P28566 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.37 |
| ▸ | HTR7 | P34969 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | HTR5A | P47898 | 1/20 | 0.37 |
| ▸ | HTR6 | P50406 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25748759 | 0.87 | HTR1A (0.74) | HTR2AHTR1AHTR2CHTR2BMPO | |
| SCHEMBL25882717 | 0.86 | HTR1A (0.58) | HTR2AHTR1AHTR2CHTR2BMPO | |
| SCHEMBL25425698 | 0.84 | HTR2A (0.54) | HTR2AHTR1AHTR2CHTR2BMPO | |
| SCHEMBL25882718 | 0.82 | HTR1A (0.50) | HTR2AHTR1AHTR2CHTR2BMPO | |
| SCHEMBL25425479 | 0.82 | HTR1A (0.56) | HTR2AHTR1AHTR2CHTR2BMPO | |
| SCHEMBL24243696 | 0.80 | HTR2A (0.76) | HTR2AHTR1AHTR2CHTR2BSLC6A2 | |
| SCHEMBL30053771 | 0.80 | HTR2A (0.76) | HTR2AHTR1AHTR2CHTR2BSLC6A2 | |
| SCHEMBL30877210 | 0.78 | HTR2A (0.64) | HTR2AHTR1AMPOSLC6A4 | |
| SCHEMBL24692764 | 0.78 | HTR2A (0.64) | HTR2AHTR1AMPOSLC6A4 | |
| SCHEMBL24243684 | 0.77 | HTR2A (0.80) | HTR2AHTR1AHTR2CHTR2BMPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250101038-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2025-03-27 | — | — | US | disclosed |
| EP-4452937-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2024-10-30 | — | — | EP | disclosed |
| WO-2023115166-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023115166-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2023-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250101038-A1 | COMPOUNDS | NLN, SLC18A2, PYGB | HTR2A 94/4885HTR1A 185/4885HTR2C 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.